tiprankstipranks
Incannex Healthcare Limited Sponsored ADR (IXHL)
NASDAQ:IXHL
US Market

Incannex Healthcare Limited Sponsored ADR (IXHL) Stock Price & Analysis

49 Followers

IXHL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.96 - $12.68
Previous Close$2.22
Volume8.72K
Average Volume (3M)317.01K
Market Cap
$35.23M
Enterprise Value$2.66M
Total Cash (Recent Filing)AU$33.36M
Total Debt (Recent Filing)AU$786.74K
Price to Earnings (P/E)-61.8
Beta1.02
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding15,873,113
10 Day Avg. Volume17,507
30 Day Avg. Volume317,015
Standard Deviation1.39
R-Squared0.12
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)1.12
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

23.66%0.73%3.65%71.96%
23.66% Insiders
3.65% Other Institutional Investors
71.96% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

IXHL FAQ

What was Incannex Healthcare Limited Sponsored ADR’s price range in the past 12 months?
Incannex Healthcare Limited Sponsored ADR lowest stock price was $1.96 and its highest was $12.68 in the past 12 months.
    What is Incannex Healthcare Limited Sponsored ADR’s market cap?
    Currently, no data Available
    When is Incannex Healthcare Limited Sponsored ADR’s upcoming earnings report date?
    Incannex Healthcare Limited Sponsored ADR’s upcoming earnings report date is Aug 28, 2024 which is in 119 days.
      How were Incannex Healthcare Limited Sponsored ADR’s earnings last quarter?
      Incannex Healthcare Limited Sponsored ADR released its earnings results on Feb 27, 2024. The company reported -$0.33 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.33.
        Is Incannex Healthcare Limited Sponsored ADR overvalued?
        According to Wall Street analysts Incannex Healthcare Limited Sponsored ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Incannex Healthcare Limited Sponsored ADR pay dividends?
          Incannex Healthcare Limited Sponsored ADR does not currently pay dividends.
          What is Incannex Healthcare Limited Sponsored ADR’s EPS estimate?
          Incannex Healthcare Limited Sponsored ADR’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Incannex Healthcare Limited Sponsored ADR have?
          Incannex Healthcare Limited Sponsored ADR has 15,870,118 shares outstanding.
            What happened to Incannex Healthcare Limited Sponsored ADR’s price movement after its last earnings report?
            Incannex Healthcare Limited Sponsored ADR reported an EPS of -$0.33 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.347%.
              Which hedge fund is a major shareholder of Incannex Healthcare Limited Sponsored ADR?
              Currently, no hedge funds are holding shares in IXHL
              ---

              Incannex Healthcare Limited Sponsored ADR Stock Smart Score

              Company Description

              Incannex Healthcare Limited Sponsored ADR

              Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Immuron
              Corbus Pharmaceuticals
              Aurora Cannabis
              Advaxis
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis